Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomes.
Sobha SivaprasadFaruque D GhanchiSimon P KellyAjay KotagiriJames Stephen TalksPeter Henry ScanlonHellen McGoeyAndrew NolanMoneeb SaddiqJackie Napiernull nullPublished in: Eye (London, England) (2021)
Year one results indicated that IVT-AFL was an effective treatment for DMO in standard of care UK clinical practice, maintaining or improving visual acuity in treatment-naive patients with good baseline visual acuity, despite some patients being undertreated versus the summary of product characteristics. These results also demonstrated the clinical importance and meaningful impact of diabetic retinopathy screening in the UK.
Keyphrases
- diabetic retinopathy
- healthcare
- end stage renal disease
- ejection fraction
- newly diagnosed
- type diabetes
- chronic pain
- adipose tissue
- metabolic syndrome
- skeletal muscle
- pain management
- replacement therapy
- weight loss
- smoking cessation
- health insurance
- insulin resistance
- patient reported
- antiretroviral therapy
- glycemic control
- affordable care act